Third ventriculostomy in infants younger than 1 year old

Area of Science:

• Neurosurgery
• Pediatric Neurosurgery
• Hydrocephalus Management

Background:

• Endoscopic third ventriculostomy (ETV) is increasingly utilized for hydrocephalus treatment.
• Previous studies debated ETV's efficacy in infants under one year old.
• Emerging evidence suggests hydrocephalus etiology, not patient age, is key to ETV success.

Purpose of the Study:

• To retrospectively evaluate the effectiveness of ETV in hydrocephalus treatment.
• To determine if patient age or hydrocephalus etiology influences ETV success rates.

Main Methods:

• Retrospective analysis of 75 endoscopic procedures, including 48 ETVs.
• Patient groups were stratified by hydrocephalus etiology: aqueductal stenosis, Dandy-Walker malformation, and Chiari type II malformation.
• Success rates were analyzed based on etiology and age groups.

Main Results:

• ETV success rates varied significantly by etiology: 90% for aqueductal stenosis, 50% for Chiari type II.
• No statistically significant difference in ETV success was observed when patients were stratified by age groups.
• Etiology-driven outcomes highlight specific indications for ETV.

Conclusions:

• The effectiveness of ETV in hydrocephalus treatment is primarily linked to the underlying etiology.
• Patient age is not a significant factor in determining ETV success.
• ETV is a viable treatment for hydrocephalus, with outcomes dependent on the specific cause.